Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Cardiology|April 18, 2015
Adaptive cardiovascular hormones in a spectrum of heart failure phenotypesStanislava Zabarovskaja, Camilla Hage, Cecilia Linde, et al.
Diabetes & Vascular Disease Research|February 11, 2017
Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohortViveca Ritsinger, Kerstin Brismar, Klas Malmberg, et al.
Diabetes & Vascular Disease Research|May 19, 2016
Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction studyLisa Arnetz, Camilla Hage, Kerstin Brismar, et al.
Cardiovascular Diabetology|August 11, 2023
Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trialElena Fortin, Magnus Lundin, Linda Mellbin, et al.
The Lancet. Diabetes & Endocrinology|September 26, 2024
Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studiesGiulia Ferrannini, Jaakko Tuomilehto, Guy De Backer, et al.
Journal of Cardiac Failure|May 13, 2022
Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure PopulationTonje Thorvaldsen, Giulia Ferrannini, Linda Mellbin, et al.
Diabetes Care|June 23, 2017
The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of CardiologyBahira Shahim, Dirk De Bacquer, Guy De Backer, et al.
Cardiovascular Diabetology|February 12, 2021
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveysGiulia Ferrannini, Dirk De Bacquer, Pieter Vynckier, et al.
Diabetes|January 9, 2026
Long Duration of Type 2 Diabetes Drives Erythrocyte-Induced Vascular Endothelial Dysfunction: A Link to miRNA-210-3pEftychia Kontidou, Aida Collado, Rawan Humoud, et al.
Diabetes Research and Clinical Practice|November 6, 2022
SOdium-glucose CO-transporter inhibition in patients with newly detected Glucose Abnormalities and a recent Myocardial Infarction (SOCOGAMI)Magnus Lundin, Giulia Ferrannini, Linda Mellbin, et al.
Pageof 7